{"id":16052,"date":"2020-01-31T06:00:23","date_gmt":"2020-01-31T06:00:23","guid":{"rendered":"https:\/\/fight-malaria-blog.local\/?p=16052"},"modified":"2020-01-29T21:27:38","modified_gmt":"2020-01-29T21:27:38","slug":"optimising-vaccine-efficacy-using-tobacco-mosaic-virus","status":"publish","type":"post","link":"https:\/\/fight-malaria-blog.local\/malaria-minute\/optimising-vaccine-efficacy-using-tobacco-mosaic-virus\/","title":{"rendered":"Optimising Vaccine Efficacy Using Tobacco Mosaic Virus"},"content":{"rendered":"
Use of the tobacco mosaic virus platform to administer malaria antigens induces high and durable efficacy in macaques and individuals with an African-centric genetic variation may have an improved response to malaria.<\/p>\n